Alexion snares OK for quicker-infusing Ultomiris formula—and a subQ version is on the horizon Inhaled antibody drug for COVID-19 clears coronavirus in animals Good vibrations: ETH Zurich scientists tap ultrasound for targeted drug delivery to the brain 3M spinoff Kindeva Drug Delivery plots new Minnesota operations center Sunovion focuses on Kynmobi's easy dosing as it launches into crowded Parkinson's market The top 10 takeover targets in biopharma Featured Story | By Fraiser Kansteiner Rare disease drugmaker Alexion has wasted no time converting patients to Ultomiris, the successor to its rare disease blockbuster Soliris. Now, it hopes to make that switch even easier with a newly approved formulation that aims to cut infusion times by 60%. read more |
| |
|---|
|
Top Stories By Angus Liu An inhaled neutralizing antibody cleared the novel coronavirus from infected hamsters at a far lower dose compared with other experimental monoclonal antibodies. The drug is now being developed by Aridis Pharmaceuticals and could offer a self-administered option for COVID-19 if it succeeds in human testing. read more By Fraiser Kansteiner Researchers at ETH Zurich say they’ve developed a new method for concentrating and releasing drugs in the brain. With a promising rat trial under their belts, the scientists think their lipid-ultrasound system could eventually be used to deliver safer treatments for mental health and neurological disorders, as well as cancers. read more By Fraiser Kansteiner 3M spinoff Kindeva Drug Delivery is expanding its St. Paul, Minnesota, operations, with plans to break ground on a 136,000-square-foot operations center in the city's Woodbury area. The site, pegged to receive state funding, will boast a distribution center and light industrial area. read more By Beth Snyder Bulik Can Sunovion cast Kynmobi as a more convenient alternative for Parkinson’s disease symptom treatment in an already crowded market? That’s the strategy, as Kynmobi launches with an easy dosing message. read more By Phil Taylor Most if not all large-cap pharma and biotech companies are still in need of business development as they work to rebalance their operations. Cancer, rare disease, and to a lesser extent central nervous system players are targets that match up most closely with prospective buyers. read more Resources Sponsored By: Paysign Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all. Sponsored by: Aldevron Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Sponsored By: Elligo Health Research® Understanding the Challenges COVID-19 Pediatric Clinical Trials Face | White Paper Sponsored By: Outer Edge Technology A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Sponsored By: ICON Clinical Research Ltd The culture of clinical research is evolving from one directed by researchers to one driven by the needs of patients and those who care for them. Sponsored By: The PerkinElmer Signals Screening Team Creating integrated HCS workflows in a single platform increases accuracy; reduces time and helps to identify the most appropriate hits or drug candidates. Learn more about a reliable method for creating a more efficient, faster, 3D image and multi-parametric data analysis workflow. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Cascade Chemistry, API CDMO Struggling with complex chemistry to get APIs for clinical trials? Find out what to look for in an API CDMO partner to gain expertise and speed that lead to success. Sponsored by: EVERSANA An integrated compliance model can be the competitive differentiator to commercialization and move the needle from cost center to value. Learn How. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Formedix Learn how to save time and reduce costs and complexity by streamlining the clinical trial process. Sponsored by: LabVantage Want to leapfrog lengthy LIMS deployments and position your pharmaceutical lab for success? Find out how with LabVantage Solutions. Sponsored by: Thermo Fisher Scientific Learn how to safeguard supply, improve distribution and reduce program costs and risks Sponsored by: Clinical Ink Learn how the right data capture solution can prompt the patient to follow the correct procedures and automatically sort the responses, according to protocol. Sponsored by: Guidehouse While COVID-19 has shifted the rules of the healthcare industry, research shows there was already progress on changes being made for how pharma companies are launching products. Sponsored by: Blue Matter Consulting Senior executives from 16 biopharma companies share their thoughts on how COVID-19 will change how the industry engages with its customers. A complete Life Science Industry Snapshot in One Report Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Clinical Quality Oversight Forum October 20-22, 2020 | Virtual Event 2nd Annual Gene Therapy Analytical Development November 30 – December 3, 2020 | 100% Online | 